Importantly, we did not find any significant impact of either cisplatin or Tranilast on ATOX1 expression in hepatic HepG2 cells (Figure S5D), indicating that ATOX1 might be targeted by Tranilast in a safe tumor-specific manner. Here, ATOX1 is linked to neoplasm.